tiprankstipranks
Solvonis Therapeutics plc (GB:SVNS)
LSE:SVNS
UK Market

Solvonis Therapeutics (SVNS) Technical Analysis

12 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Solvonis Therapeutics plc’s (SVNS) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Solvonis Therapeutics plc is a Sell.
Solvonis Therapeutics plc’s (SVNS) 20-Day exponential moving average is 0.24, while Solvonis Therapeutics plc’s (SVNS) share price is 0.35 p, making it a Buy.
Solvonis Therapeutics plc’s (SVNS) 50-Day exponential moving average is 0.25, while Solvonis Therapeutics plc’s (SVNS) share price is 0.35 p, making it a Buy.

Solvonis Therapeutics (SVNS) Pivot Points

Apr 09, 2026, 08:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.18
0.21
0.23
0.26
0.28
0.31
0.33
Fibonacci
0.21
0.23
0.24
0.26
0.28
0.29
0.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Solvonis Therapeutics (SVNS) Moving Averages

Apr 09, 2026, 08:07 AM
Period
Simple
Exponential
MA5
0.25Buy
0.25Buy
MA10
0.24Buy
0.25Buy
MA20
0.24Buy
0.24Buy
MA50
0.24Buy
0.25Buy
MA100
0.26Buy
0.26Buy
MA200
0.28Sell
0.25Buy
Solvonis Therapeutics plc’s (SVNS) 10-Day exponential moving average is 0.25, while Solvonis Therapeutics plc’s (SVNS) share price is 0.35 p, making it a Buy.
Solvonis Therapeutics plc’s (SVNS) 100-Day exponential moving average is 0.26, while Solvonis Therapeutics plc’s (SVNS) share price is 0.35 p, making it a Buy.
Solvonis Therapeutics plc’s (SVNS) stock price is 0.35 p and Solvonis Therapeutics plc’s (SVNS) 50-day simple moving average is 0.24, creating a Buy signal.
Solvonis Therapeutics plc’s (SVNS) stock price is 0.35 p and Solvonis Therapeutics plc’s (SVNS) 100-day simple moving average is 0.26, creating a Buy signal.
Solvonis Therapeutics plc’s (SVNS) stock price is 0.35 p and Solvonis Therapeutics plc’s (SVNS) 200-day simple moving average is 0.28, creating a Sell signal.

Solvonis Therapeutics (SVNS) Technical Indicators

Apr 09, 2026, 08:07 AM
Name
Value
Implied Action
RSI (14)
62.74
Neutral
STOCH (9,6)
70.20
Neutral
STOCHRSI (14)
70.56
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
11.69
Buy
Williams %R
-14.29
Sell
CCI (14)
209.30
Sell
ATR (14)
0.03
-
Ultimate Oscillator
46.45
Neutral
ROC
12.50
Buy
Solvonis Therapeutics plc’s (SVNS) Relative Strength Index (RSI) is 62.74, creating a Neutral signal.
Solvonis Therapeutics plc’s (SVNS) Trend Strength Indicator (ADX) is 11.69, creating a Buy signal.
Solvonis Therapeutics plc’s (SVNS) Commodity Channel Index (CCI) is 209.30, creating a Sell signal.
Solvonis Therapeutics plc’s (SVNS) Price Rate of Change (ROC) is 12.50, creating a Buy signal.

FAQ

Is SVNS a Buy, Hold, or Sell?
Based on SVNS’s technical indicators, SVNS is a Buy.
    What is SVNS’s RSI (14)?
    SVNS’s RSI (14) is 62.74, which suggests SVNS is a Neutral.
      What is SVNS’s MACD?
      SVNS’s MACD is <0.01, which suggests SVNS is a Sell.
        What is SVNS’s 5-day moving average?
        SVNS’s 5-day moving average is 0.25, which suggests SVNS is a Buy.
          What is SVNS’s 20-day moving average?
          SVNS 20-day moving average is 0.24, which suggests SVNS is a Buy.
            What is SVNS’s 50-day moving average?
            SVNS’s 50-day moving average is 0.24, which suggests SVNS is a Buy.
              What is SVNS’s 200-day moving average?
              SVNS’s 200-day moving average is 0.28, which suggests SVNS is a Sell.
                What is SVNS’s Williams % R (14)?
                SVNS’s Williams % R (14) is -14.29, which suggests SVNS is a Sell.
                  What is SVNS’s CCI (14)?
                  SVNS’s CCI (14) is 209.30, which suggests SVNS is a Sell.
                    What is the share price of Solvonis Therapeutics plc?